<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2020-10-07" version="209">
<accession>Q01105</accession>
<accession>A5A5H4</accession>
<accession>A6NGV1</accession>
<accession>B4DUE2</accession>
<accession>Q15541</accession>
<accession>Q5VXV1</accession>
<accession>Q5VXV2</accession>
<accession>Q6FHZ5</accession>
<name>SET_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein SET</fullName>
</recommendedName>
<alternativeName>
<fullName>HLA-DR-associated protein II</fullName>
</alternativeName>
<alternativeName>
<fullName>Inhibitor of granzyme A-activated DNase</fullName>
<shortName>IGAAD</shortName>
</alternativeName>
<alternativeName>
<fullName>PHAPII</fullName>
</alternativeName>
<alternativeName>
<fullName>Phosphatase 2A inhibitor I2PP2A</fullName>
<shortName>I-2PP2A</shortName>
</alternativeName>
<alternativeName>
<fullName>Template-activating factor I</fullName>
<shortName>TAF-I</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SET</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="3346" last="3355">
<title>Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene.</title>
<authorList>
<person name="von Lindern M."/>
<person name="van Baal S."/>
<person name="Wiegant J."/>
<person name="Raap A."/>
<person name="Hagemeijer A."/>
<person name="Grosveld G."/>
</authorList>
<dbReference type="PubMed" id="1630450"/>
<dbReference type="DOI" id="10.1128/mcb.12.8.3346"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Biol. Chem. Hoppe-Seyler" volume="375" first="113" last="126">
<title>Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII.</title>
<authorList>
<person name="Vaesen M."/>
<person name="Barnikol-Watanabe S."/>
<person name="Goetz H."/>
<person name="Adil Awni L."/>
<person name="Cole T."/>
<person name="Zimmermann B."/>
<person name="Kratzin H.D."/>
<person name="Hilschmann N."/>
</authorList>
<dbReference type="PubMed" id="8192856"/>
<dbReference type="DOI" id="10.1515/bchm3.1994.375.2.113"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="4279" last="4283">
<title>Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.</title>
<authorList>
<person name="Nagata K."/>
<person name="Kawase H."/>
<person name="Handa H."/>
<person name="Yano K."/>
<person name="Yamasaki M."/>
<person name="Ishimi Y."/>
<person name="Okuda A."/>
<person name="Kikuchi A."/>
<person name="Matsumoto K."/>
</authorList>
<dbReference type="PubMed" id="7753797"/>
<dbReference type="DOI" id="10.1073/pnas.92.10.4279"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>PROTEIN SEQUENCE OF 14-35; 40-60; 75-90 AND 155-167</scope>
<scope>ACTIVATION OF DNA REPLICATION</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="11059" last="11062">
<title>The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A.</title>
<authorList>
<person name="Li M."/>
<person name="Makkinje A."/>
<person name="Damuni Z."/>
</authorList>
<dbReference type="PubMed" id="8626647"/>
<dbReference type="DOI" id="10.1074/jbc.271.19.11059"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="363" last="372">
<title>Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.</title>
<authorList>
<person name="Tsujio I."/>
<person name="Zaidi T."/>
<person name="Xu J."/>
<person name="Kotula L."/>
<person name="Grundke-Iqbal I."/>
<person name="Iqbal K."/>
</authorList>
<dbReference type="PubMed" id="15642345"/>
<dbReference type="DOI" id="10.1016/j.febslet.2004.11.097"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Halleck A."/>
<person name="Ebert L."/>
<person name="Mkoundinya M."/>
<person name="Schick M."/>
<person name="Eisenstein S."/>
<person name="Neubert P."/>
<person name="Kstrang K."/>
<person name="Schatten R."/>
<person name="Shen B."/>
<person name="Henze S."/>
<person name="Mar W."/>
<person name="Korn B."/>
<person name="Zuo D."/>
<person name="Hu Y."/>
<person name="LaBaer J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="2258" last="2262">
<title>Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia.</title>
<authorList>
<person name="Adachi Y."/>
<person name="Pavlaki G.N."/>
<person name="Copeland T.D."/>
</authorList>
<dbReference type="PubMed" id="8294483"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>CHARACTERIZATION</scope>
</reference>
<reference key="12">
<citation type="submission" date="2007-04" db="EMBL/GenBank/DDBJ databases">
<title>A relative factor in human rectum carcinoma.</title>
<authorList>
<person name="Wang L.C."/>
<person name="Chen Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-241 (ISOFORM 2)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="J. Am. Soc. Nephrol." volume="9" first="1873" last="1880">
<title>Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor.</title>
<authorList>
<person name="Carlson S.G."/>
<person name="Eng E."/>
<person name="Kim E.-G."/>
<person name="Perlman E.J."/>
<person name="Copeland T.D."/>
<person name="Ballermann B.J."/>
</authorList>
<dbReference type="PubMed" id="9773788"/>
</citation>
<scope>EXPRESSION IN THE KIDNEY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="Cell" volume="104" first="119" last="130">
<title>Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the Set oncoprotein.</title>
<authorList>
<person name="Seo S.-B."/>
<person name="McNamara P."/>
<person name="Heo S."/>
<person name="Turner A."/>
<person name="Lane W.S."/>
<person name="Chakravarti D."/>
</authorList>
<dbReference type="PubMed" id="11163245"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00196-9"/>
</citation>
<scope>INHIBITION OF HISTONE ACETYLATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Eur. J. Biochem." volume="268" first="1340" last="1351">
<title>Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET.</title>
<authorList>
<person name="Minakuchi M."/>
<person name="Kakazu N."/>
<person name="Gorrin-Rivas M.J."/>
<person name="Abe T."/>
<person name="Copeland T.D."/>
<person name="Ueda K."/>
<person name="Adachi Y."/>
</authorList>
<dbReference type="PubMed" id="11231286"/>
<dbReference type="DOI" id="10.1046/j.1432-1327.2001.02000.x"/>
</citation>
<scope>INTERACTION WITH SETBP1</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="43285" last="43293">
<title>Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks.</title>
<authorList>
<person name="Beresford P.J."/>
<person name="Zhang D."/>
<person name="Oh D.Y."/>
<person name="Fan Z."/>
<person name="Greer E.L."/>
<person name="Russo M.L."/>
<person name="Jaju M."/>
<person name="Lieberman J."/>
</authorList>
<dbReference type="PubMed" id="11555662"/>
<dbReference type="DOI" id="10.1074/jbc.m108137200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AN32A</scope>
<scope>PROTEOLYTIC CLEAVAGE AT LYS-179 BY GZMA (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="2810" last="2820">
<title>HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A.</title>
<authorList>
<person name="Fan Z."/>
<person name="Beresford P.J."/>
<person name="Zhang D."/>
<person name="Lieberman J."/>
</authorList>
<dbReference type="PubMed" id="11909973"/>
<dbReference type="DOI" id="10.1128/mcb.22.8.2810-2820.2002"/>
</citation>
<scope>INTERACTION WITH HMGB2</scope>
<scope>IDENTIFICATION IN THE SET COMPLEX</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Cell" volume="112" first="659" last="672">
<title>Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.</title>
<authorList>
<person name="Fan Z."/>
<person name="Beresford P.J."/>
<person name="Oh D.Y."/>
<person name="Zhang D."/>
<person name="Lieberman J."/>
</authorList>
<dbReference type="PubMed" id="12628186"/>
<dbReference type="DOI" id="10.1016/s0092-8674(03)00150-8"/>
</citation>
<scope>FUNCTION IN NME1 INHIBITION</scope>
<scope>INTERACTION WITH NME1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DESCRIPTION OF THE SET COMPLEX</scope>
<scope>PROTEOLYTIC CLEAVAGE BY GZMA</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Cell" volume="115" first="241" last="241">
<authorList>
<person name="Fan Z."/>
<person name="Beresford P.J."/>
<person name="Oh D.Y."/>
<person name="Zhang D."/>
<person name="Lieberman J."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:12628186</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="J. Gen. Virol." volume="84" first="2501" last="2510">
<title>Herpes simplex virus type 1 tegument protein VP22 interacts with TAF-I proteins and inhibits nucleosome assembly but not regulation of histone acetylation by INHAT.</title>
<authorList>
<person name="van Leeuwen H."/>
<person name="Okuwaki M."/>
<person name="Hong R."/>
<person name="Chakravarti D."/>
<person name="Nagata K."/>
<person name="O'Hare P."/>
</authorList>
<dbReference type="PubMed" id="12917472"/>
<dbReference type="DOI" id="10.1099/vir.0.19326-0"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 VP22 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Nat. Immunol." volume="4" first="145" last="153">
<title>Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A.</title>
<authorList>
<person name="Fan Z."/>
<person name="Beresford P.J."/>
<person name="Zhang D."/>
<person name="Xu Z."/>
<person name="Novina C.D."/>
<person name="Yoshida A."/>
<person name="Pommier Y."/>
<person name="Lieberman J."/>
</authorList>
<dbReference type="PubMed" id="12524539"/>
<dbReference type="DOI" id="10.1038/ni885"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="Mol. Cell" volume="23" first="133" last="142">
<title>The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death.</title>
<authorList>
<person name="Chowdhury D."/>
<person name="Beresford P.J."/>
<person name="Zhu P."/>
<person name="Zhang D."/>
<person name="Sung J.S."/>
<person name="Demple B."/>
<person name="Perrino F.W."/>
<person name="Lieberman J."/>
</authorList>
<dbReference type="PubMed" id="16818237"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.06.005"/>
</citation>
<scope>INTERACTION WITH TREX1</scope>
<scope>IDENTIFICATION IN THE SET COMPLEX</scope>
<scope>PROTEOLYTIC CLEAVAGE BY GZMA</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Nature" volume="441" first="46" last="52">
<title>Shugoshin collaborates with protein phosphatase 2A to protect cohesin.</title>
<authorList>
<person name="Kitajima T.S."/>
<person name="Sakuno T."/>
<person name="Ishiguro K."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Kawashima S.A."/>
<person name="Watanabe Y."/>
</authorList>
<dbReference type="PubMed" id="16541025"/>
<dbReference type="DOI" id="10.1038/nature04663"/>
</citation>
<scope>INTERACTION WITH SGO1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E5071" last="E5071">
<title>FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4.</title>
<authorList>
<person name="Kajiwara Y."/>
<person name="Akram A."/>
<person name="Katsel P."/>
<person name="Haroutunian V."/>
<person name="Schmeidler J."/>
<person name="Beecham G."/>
<person name="Haines J.L."/>
<person name="Pericak-Vance M.A."/>
<person name="Buxbaum J.D."/>
</authorList>
<dbReference type="PubMed" id="19343227"/>
<dbReference type="DOI" id="10.1371/journal.pone.0005071"/>
</citation>
<scope>INTERACTION WITH APBB1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-150 AND LYS-172</scope>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-11 (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-24 (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-24 (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28 AND SER-63</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="PLoS Genet." volume="10" first="E1004772" last="E1004772">
<title>De novo mutations in moderate or severe intellectual disability.</title>
<authorList>
<person name="Hamdan F.F."/>
<person name="Srour M."/>
<person name="Capo-Chichi J.M."/>
<person name="Daoud H."/>
<person name="Nassif C."/>
<person name="Patry L."/>
<person name="Massicotte C."/>
<person name="Ambalavanan A."/>
<person name="Spiegelman D."/>
<person name="Diallo O."/>
<person name="Henrion E."/>
<person name="Dionne-Laporte A."/>
<person name="Fougerat A."/>
<person name="Pshezhetsky A.V."/>
<person name="Venkateswaran S."/>
<person name="Rouleau G.A."/>
<person name="Michaud J.L."/>
</authorList>
<dbReference type="PubMed" id="25356899"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1004772"/>
</citation>
<scope>INVOLVEMENT IN MRD58</scope>
<scope>VARIANT MRD58 233-TYR--ASP-290 DEL</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2018" name="Hum. Mutat." volume="39" first="1014" last="1023">
<title>De novo mutations in the SET nuclear proto-oncogene, encoding a component of the inhibitor of histone acetyltransferases (INHAT) complex in patients with nonsyndromic intellectual disability.</title>
<authorList>
<consortium name="CAUSES Study"/>
<person name="Stevens S.J.C."/>
<person name="van der Schoot V."/>
<person name="Leduc M.S."/>
<person name="Rinne T."/>
<person name="Lalani S.R."/>
<person name="Weiss M.M."/>
<person name="van Hagen J.M."/>
<person name="Lachmeijer A.M.A."/>
<person name="Stockler-Ipsiroglu S.G."/>
<person name="Lehman A."/>
<person name="Brunner H.G."/>
</authorList>
<dbReference type="PubMed" id="29688601"/>
<dbReference type="DOI" id="10.1002/humu.23541"/>
</citation>
<scope>INVOLVEMENT IN MRD58</scope>
<scope>VARIANTS MRD58 GLY-95 AND TYR-118</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="4285" last="4290">
<title>Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity.</title>
<authorList>
<person name="Muto S."/>
<person name="Senda M."/>
<person name="Akai Y."/>
<person name="Sato L."/>
<person name="Suzuki T."/>
<person name="Nagai R."/>
<person name="Senda T."/>
<person name="Horikoshi M."/>
</authorList>
<dbReference type="PubMed" id="17360516"/>
<dbReference type="DOI" id="10.1073/pnas.0603762104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 38-238</scope>
<scope>DNA-BINDING</scope>
<scope>DOMAINS</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="12 14">Multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone chaperoning. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher.</text>
</comment>
<comment type="subunit">
<text evidence="11 12 13 14 16 17 18 19">Headphone-shaped homodimer. Isoforms 1 and 2 interact directly with each other and with ANP32A within the tripartite INHAT (inhibitor of acetyltransferases) complex. Isoform 1 and isoform 2 interact also with histones. Isoform 2 is a component of the SET complex, composed of at least ANP32A, APEX1, HMGB2, NME1, SET and TREX1, but not NME2 or TREX2. Within this complex, directly interacts with ANP32A, NME1, HMGB2 and TREX1; the interaction with ANP32A is enhanced after cleavage. Interacts with APBB1, CHTOP, SETBP1, SGO1.</text>
</comment>
<comment type="subunit">
<text evidence="15">(Microbial infection) Interacts with herpes simplex virus 1 VP22.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-6309082">
<id>Q6SJ93</id>
<label>FAM111B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-1108782">
<id>Q12778</id>
<label>FOXO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-748397">
<id>P50222</id>
<label>MEOX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-476431">
<id>P10644</id>
<label>PRKAR1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-413628">
<id>P63000</id>
<label>RAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-727004">
<id>O00560</id>
<label>SDCBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-2510647">
<id>Q15573</id>
<label>TAF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-1560239">
<id>Q53T94</id>
<label>TAF1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-2510659">
<id>Q15572</id>
<label>TAF1C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-355371">
<id>P20226</id>
<label>TBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-741350">
<id>Q9BT49</id>
<label>THAP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053182">
<id>Q01105</id>
</interactant>
<interactant intactId="EBI-396235">
<id>P17480</id>
<label>UBTF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-979174">
<id>Q53HL2</id>
<label>CDCA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-6309082">
<id>Q6SJ93</id>
<label>FAM111B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-747278">
<id>P26367</id>
<label>PAX6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-24236508">
<id>Q9BWE0-4</id>
<label>REPIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-727004">
<id>O00560</id>
<label>SDCBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-12111430">
<id>Q562F6-3</id>
<label>SGO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-12833746">
<id>Q5T0J7-2</id>
<label>TEX35</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-741350">
<id>Q9BT49</id>
<label>THAP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-11741437">
<id>Q08117-2</id>
<label>TLE5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-1105334">
<id>P17021</id>
<label>ZNF17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-11962468">
<id>Q7Z4V0</id>
<label>ZNF438</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7481343">
<id>Q01105-2</id>
</interactant>
<interactant intactId="EBI-18141506">
<id>Q49A12</id>
<label>ZNF85</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleoplasm</location>
</subcellularLocation>
<text>In the cytoplasm, found both in the cytosol and associated with the endoplasmic reticulum. The SET complex is associated with the endoplasmic reticulum. Following CTL attack and cleavage by GZMA, moves rapidly to the nucleus, where it is found in the nucleoplasm, avoiding the nucleolus. Similar translocation to the nucleus is also observed for lymphocyte-activated killer cells after the addition of calcium.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q01105-1</id>
<name>1</name>
<name>TAF-I alpha</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q01105-2</id>
<name>2</name>
<name>TAF-I beta</name>
<sequence type="described" ref="VSP_009868"/>
</isoform>
<isoform>
<id>Q01105-3</id>
<name>3</name>
<sequence type="described" ref="VSP_045175"/>
</isoform>
<isoform>
<id>Q01105-4</id>
<name>4</name>
<sequence type="described" ref="VSP_046741"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Widely expressed. Low levels in quiescent cells during serum starvation, contact inhibition or differentiation. Highly expressed in Wilms' tumor.</text>
</comment>
<comment type="domain">
<text evidence="18">A long alpha helix in the N-terminus mediates dimerization, while the earmuff domain is responsible for core histone and dsDNA binding. The C-terminal acidic domain mediates the inhibition of histone acetyltransferases and is required for the DNA replication stimulatory activity.</text>
</comment>
<comment type="PTM">
<text>Isoform 2 is phosphorylated on Ser-15 and Ser-24.</text>
</comment>
<comment type="PTM">
<text>Isoform 2 is acetylated on Lys-11.</text>
</comment>
<comment type="PTM">
<text evidence="9">Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="9">N-terminus of isoform 1 is methylated by METTL11A/NTM1. Mainly trimethylated (By similarity).</text>
</comment>
<comment type="PTM">
<molecule>Isoform 2</molecule>
<text evidence="12 14 17">Cleaved after Lys-176 by GZMA. The cleavage inhibits its nucleosome assembly activity and disrupts the inhibition on NME1.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving SET is found in some cases of acute undifferentiated leukemia (AUL). Translocation t(6;9)(q21;q34.1) with NUP214/CAN.</text>
</comment>
<comment type="disease" evidence="20 21">
<disease id="DI-05326">
<name>Mental retardation, autosomal dominant 58</name>
<acronym>MRD58</acronym>
<description>A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD58 is characterized by delayed development, intellectual disability, language delay and speech impairment. Some patients have motor delay or incoordination, and minor dysmorphic features.</description>
<dbReference type="MIM" id="618106"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the nucleosome assembly protein (NAP) family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SETID42272ch9q34.html"/>
</comment>
<dbReference type="EMBL" id="M93651">
<property type="protein sequence ID" value="AAA60318.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X75091">
<property type="protein sequence ID" value="CAA52982.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D45198">
<property type="protein sequence ID" value="BAA08139.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U51924">
<property type="protein sequence ID" value="AAC50460.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY349172">
<property type="protein sequence ID" value="AAQ79833.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR536543">
<property type="protein sequence ID" value="CAG38780.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR542050">
<property type="protein sequence ID" value="CAG46847.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223556">
<property type="protein sequence ID" value="BAD97276.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300609">
<property type="protein sequence ID" value="BAG62304.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356481">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL359678">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032749">
<property type="protein sequence ID" value="AAH32749.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF534308">
<property type="protein sequence ID" value="ABP96841.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS48037.1">
<molecule id="Q01105-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59149.1">
<molecule id="Q01105-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6907.1">
<molecule id="Q01105-2"/>
</dbReference>
<dbReference type="PIR" id="A57984">
<property type="entry name" value="A45018"/>
</dbReference>
<dbReference type="PIR" id="I59377">
<property type="entry name" value="I59377"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001116293.1">
<molecule id="Q01105-1"/>
<property type="nucleotide sequence ID" value="NM_001122821.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001234929.1">
<molecule id="Q01105-4"/>
<property type="nucleotide sequence ID" value="NM_001248000.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001234930.1">
<property type="nucleotide sequence ID" value="NM_001248001.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003002.2">
<molecule id="Q01105-2"/>
<property type="nucleotide sequence ID" value="NM_003011.3"/>
</dbReference>
<dbReference type="PDB" id="2E50">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/P/Q=38-238"/>
</dbReference>
<dbReference type="PDBsum" id="2E50"/>
<dbReference type="SMR" id="Q01105"/>
<dbReference type="BioGRID" id="112316">
<property type="interactions" value="170"/>
</dbReference>
<dbReference type="CORUM" id="Q01105"/>
<dbReference type="DIP" id="DIP-33561N"/>
<dbReference type="IntAct" id="Q01105">
<property type="interactions" value="124"/>
</dbReference>
<dbReference type="MINT" id="Q01105"/>
<dbReference type="STRING" id="9606.ENSP00000361777"/>
<dbReference type="ChEMBL" id="CHEMBL4295798"/>
<dbReference type="iPTMnet" id="Q01105"/>
<dbReference type="PhosphoSitePlus" id="Q01105"/>
<dbReference type="SwissPalm" id="Q01105"/>
<dbReference type="BioMuta" id="SET"/>
<dbReference type="DMDM" id="46397790"/>
<dbReference type="EPD" id="Q01105"/>
<dbReference type="jPOST" id="Q01105"/>
<dbReference type="MassIVE" id="Q01105"/>
<dbReference type="PaxDb" id="Q01105"/>
<dbReference type="PeptideAtlas" id="Q01105"/>
<dbReference type="PRIDE" id="Q01105"/>
<dbReference type="ProteomicsDB" id="1156"/>
<dbReference type="ProteomicsDB" id="57917">
<molecule id="Q01105-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57918">
<molecule id="Q01105-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="65617"/>
<dbReference type="TopDownProteomics" id="Q01105-1">
<molecule id="Q01105-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q01105-2">
<molecule id="Q01105-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="3931">
<property type="antibodies" value="359 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6418"/>
<dbReference type="Ensembl" id="ENST00000322030">
<molecule id="Q01105-2"/>
<property type="protein sequence ID" value="ENSP00000318012"/>
<property type="gene ID" value="ENSG00000119335"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000372686">
<molecule id="Q01105-3"/>
<property type="protein sequence ID" value="ENSP00000361771"/>
<property type="gene ID" value="ENSG00000119335"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000372692">
<molecule id="Q01105-1"/>
<property type="protein sequence ID" value="ENSP00000361777"/>
<property type="gene ID" value="ENSG00000119335"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000409104">
<molecule id="Q01105-4"/>
<property type="protein sequence ID" value="ENSP00000387321"/>
<property type="gene ID" value="ENSG00000119335"/>
</dbReference>
<dbReference type="GeneID" id="6418"/>
<dbReference type="KEGG" id="hsa:6418"/>
<dbReference type="UCSC" id="uc004bvu.5">
<molecule id="Q01105-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6418"/>
<dbReference type="DisGeNET" id="6418"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000119335.16"/>
<dbReference type="GeneCards" id="SET"/>
<dbReference type="HGNC" id="HGNC:10760">
<property type="gene designation" value="SET"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000119335">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="SET"/>
<dbReference type="MIM" id="600960">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618106">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q01105"/>
<dbReference type="OpenTargets" id="ENSG00000119335"/>
<dbReference type="Orphanet" id="178469">
<property type="disease" value="Autosomal dominant non-syndromic intellectual disability"/>
</dbReference>
<dbReference type="Orphanet" id="99861">
<property type="disease" value="Precursor T-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA35678"/>
<dbReference type="eggNOG" id="KOG1508">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154891"/>
<dbReference type="HOGENOM" id="CLU_051687_4_0_1"/>
<dbReference type="InParanoid" id="Q01105"/>
<dbReference type="KO" id="K11290"/>
<dbReference type="OMA" id="LWPGAIK"/>
<dbReference type="OrthoDB" id="1191764at2759"/>
<dbReference type="PhylomeDB" id="Q01105"/>
<dbReference type="TreeFam" id="TF313386"/>
<dbReference type="PathwayCommons" id="Q01105"/>
<dbReference type="Reactome" id="R-HSA-2299718">
<property type="pathway name" value="Condensation of Prophase Chromosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450520">
<property type="pathway name" value="HuR (ELAVL1) binds and stabilizes mRNA"/>
</dbReference>
<dbReference type="SIGNOR" id="Q01105"/>
<dbReference type="BioGRID-ORCS" id="6418">
<property type="hits" value="147 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SET">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q01105"/>
<dbReference type="GeneWiki" id="Protein_SET"/>
<dbReference type="GenomeRNAi" id="6418"/>
<dbReference type="Pharos" id="Q01105">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q01105"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="RNAct" id="Q01105">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000119335">
<property type="expression patterns" value="Expressed in substantia nigra and 250 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q01105">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q01105">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid droplet"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004864">
<property type="term" value="F:protein phosphatase inhibitor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019888">
<property type="term" value="F:protein phosphatase regulator activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0035067">
<property type="term" value="P:negative regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006334">
<property type="term" value="P:nucleosome assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006337">
<property type="term" value="P:nucleosome disassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043488">
<property type="term" value="P:regulation of mRNA stability"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR037231">
<property type="entry name" value="NAP-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002164">
<property type="entry name" value="NAP_family"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11875">
<property type="entry name" value="PTHR11875"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00956">
<property type="entry name" value="NAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF143113">
<property type="entry name" value="SSF143113"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0143">Chaperone</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="10">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Protein SET" id="PRO_0000185662">
<location>
<begin position="2"/>
<end position="290"/>
</location>
</feature>
<feature type="region of interest" description="Dimerization">
<location>
<begin position="31"/>
<end position="78"/>
</location>
</feature>
<feature type="region of interest" description="Earmuff domain">
<location>
<begin position="79"/>
<end position="225"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (highly acidic)">
<location>
<begin position="239"/>
<end position="290"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form SET-CAN oncogene">
<location>
<begin position="283"/>
<end position="284"/>
</location>
</feature>
<feature type="modified residue" description="N,N,N-trimethylalanine" evidence="10">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 5 8">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="28"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="63"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="10">
<location>
<position position="68"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="146"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="150"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="172"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)">
<location>
<position position="154"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_009868" evidence="23 24 25 26 27 28 29 30 31">
<original>MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKG</original>
<variation>MSAPAAKVSKKELNSNHDGADETS</variation>
<location>
<begin position="1"/>
<end position="37"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_045175" evidence="22">
<original>MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKG</original>
<variation>MPRSHQPPPPPH</variation>
<location>
<begin position="1"/>
<end position="37"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_046741" evidence="32">
<original>MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKG</original>
<variation>MGCRDLLPSLKPTLL</variation>
<location>
<begin position="1"/>
<end position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD58; dbSNP:rs1554776500." id="VAR_081147" evidence="21">
<original>W</original>
<variation>G</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD58; dbSNP:rs1564360978." id="VAR_081148" evidence="21">
<original>H</original>
<variation>Y</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD58." id="VAR_078653" evidence="20">
<location>
<begin position="233"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="37"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="94"/>
<end position="100"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="103"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="111"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="117"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="120"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="135"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="145"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="150"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="203"/>
<end position="206"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="215"/>
<end position="223"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="224"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="230"/>
<end position="233"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location sequence="Q01105-2">
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location sequence="Q01105-2">
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location sequence="Q01105-2">
<position position="24"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1141138." id="VAR_082865" evidence="32">
<original>P</original>
<variation>Q</variation>
<location sequence="Q01105-2">
<position position="4"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2E50"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9EQU5"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11231286"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11555662"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11909973"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12628186"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12917472"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16541025"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16818237"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17360516"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19343227"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25356899"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29688601"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15642345"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1630450"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7753797"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8192856"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8626647"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source ref="12"/>
</evidence>
<evidence key="30" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="31" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="290" mass="33489" checksum="F4664118171EF230" modified="2004-04-13" version="3">MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKGEKEQQEAIEHIDEVQNEIDRLNEQASEEILKVEQKYNKLRQPFFQKRSELIAKIPNFWVTTFVNHPQVSALLGEEDEEALHYLTRVEVTEFEDIKSGYRIDFYFDENPYFENKVLSKEFHLNESGDPSSKSTEIKWKSGKDLTKRSSQTQNKASRKRQHEEPESFFTWFTDHSDAGADELGEVIKDDIWPNPLQYYLVPDMDDEEGEGEEDDDDDEEEEGLEDIDEEGDEDEGEEDEDDDEGEEGEEDEGEDD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

